List of works - Axel Seher

A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting - An in vitro study

scientific article published on 04 February 2019

Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines

scientific article published on 12 January 2018

Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion

scientific article published on 15 August 2016

HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings

scientific article published on 20 November 2020

MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer

scientific article published on 15 October 2017

MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.

scientific article published on 19 January 2018

Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer

scientific article published on 24 December 2017

MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma

scientific article published on 17 January 2019

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro

scientific article published on 28 June 2019

Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro

scientific article published on 02 June 2020

Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro

scientific article published on 10 July 2017

Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro

scientific article published on 19 July 2019

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma

scientific article published on 11 January 2020

The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy ⬇️

scientific article published on 15 March 2019

The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent.

scientific article

Utilizing BMP-2 muteins for treatment of multiple myeloma